Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Gross Margin

Albireo Pharma Inc Gross Margin Chart (ALBO)

Albireo Pharma Inc annual/quarterly Gross Margin from 2015 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Albireo Pharma Inc Gross Margin for the quarter ending June 06, 2020 was $100m a 0.00% decrease of 0m year over year
  • Albireo Pharma Inc Gross Margin for the last 12 months ending June 06, 2020 was $100m a 0.00% decrease of 0m year over year
  • Albireo Pharma Inc Annual Gross Margin for 2019 was $100m a 0.00% decrease of 0m from 2018
  • Albireo Pharma Inc Annual Gross Margin for 2018 was $100m a 0.00% decrease of 0m from 2017
  • Albireo Pharma Inc Annual Gross Margin for 2017 was $100m a 0.00% decrease of 0m from 2016
Other Margins & Efficiency Metrics:
  • Albireo Pharma Inc EBITDA Margin for the quarter ending March 03, 2018 was $-5m
  • Albireo Pharma Inc Return on Capital % for the quarter ending September 09, 2018 was -22.13 a -46.96% increase of 10.39 year over year
  • Albireo Pharma Inc Return on Equity % for the quarter ending September 09, 2018 was -39.21 a 23.24% decrease of -9.11 year over year
View Chart On Koyfin

Quarterly ALBO Gross Margin Data

06/2020$100m
03/2020$100m
12/2019$100m
09/2019$100m
06/2019$100m
03/2019$100m
12/2018$100m
09/2018$100m
06/2018$100m
03/2018$100m

Annual ALBO Gross Margin Data

2019$100m
2018$100m
2017$100m
2016$100m
2015$100m
2014$100m